These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18050773)

  • 1. Responding to the HIV epidemic in the developing world. Capacity building and technology transfer for monitoring with HAART: a Caribbean experience.
    Abayomi A; Adomakoh N; Adomakoh S
    Afr J Med Med Sci; 2006 Dec; 35 Suppl():19-24. PubMed ID: 18050773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human immunodeficiency virus epidemic: a race against time for millions and the role of flow cytometry. A Caribbean and resource-constrained country perspective.
    Abayomi A
    Cytometry B Clin Cytom; 2007 Nov; 72(6):478-81. PubMed ID: 17421027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral treatment in resource-poor settings: public health research priorities.
    Jaffar S; Govender T; Garrib A; Welz T; Grosskurth H; Smith PG; Whittle H; Bennish ML
    Trop Med Int Health; 2005 Apr; 10(4):295-9. PubMed ID: 15807791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometry as the spearhead for delivering sustainable and versatile laboratory services to HIV-burdened health care systems of the developing world: a Caribbean model.
    Abayomi EA; Landis RC
    Cytometry B Clin Cytom; 2008; 74 Suppl 1():S80-9. PubMed ID: 18228563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. World Health Organization/HIVResNet Drug Resistance Laboratory Strategy.
    Bertagnolio S; Derdelinckx I; Parker M; Fitzgibbon J; Fleury H; Peeters M; Schuurman R; Pillay D; Morris L; Tanuri A; Gershy-Damet GM; Nkengasong J; Gilks CF; Sutherland D; Sandstrom P
    Antivir Ther; 2008; 13 Suppl 2():49-57. PubMed ID: 18575191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inequalities in health: access to treatment for HIV/AIDS.
    Giuliano M; Vella S
    Ann Ist Super Sanita; 2007; 43(4):313-6. PubMed ID: 18209264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wireless networks for surveillance, data capture and data management in the human immunodeficiency virus epidemic care and treatment programmes.
    Abayomi A; Goodridge W; Asika O
    Afr J Med Med Sci; 2006 Dec; 35 Suppl():149-52. PubMed ID: 18050790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa.
    Andrews JR; Shah NS; Gandhi N; Moll T; Friedland G;
    J Infect Dis; 2007 Dec; 196 Suppl 3():S482-90. PubMed ID: 18181698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic.
    Lima VD; Johnston K; Hogg RS; Levy AR; Harrigan PR; Anema A; Montaner JS
    J Infect Dis; 2008 Jul; 198(1):59-67. PubMed ID: 18498241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to HAART: Africans take medicines more faithfully than North Americans.
    Attaran A
    PLoS Med; 2007 Feb; 4(2):e83. PubMed ID: 17326715
    [No Abstract]   [Full Text] [Related]  

  • 11. When to initiate highly active antiretroviral therapy in low-resource settings: the Moroccan experience.
    Loubiere S; el Filal KM; Sodqi M; Loundou A; Luchini S; Cleary S; Moatti JP; Himmich H
    Antivir Ther; 2008; 13(2):241-51. PubMed ID: 18505175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Human resource capacity building on TB laboratory work for TB control program--through the experience of international TB laboratory training course for TB control at the Research Institute of Tuberculosis, JATA, Japan].
    Fujiki A; Kato S
    Kekkaku; 2008 Jun; 83(6):475-9. PubMed ID: 18634453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scale-up of HIV care and treatment: can it transform healthcare services in resource-limited settings?
    El-Sadr WM; Abrams EJ
    AIDS; 2007 Oct; 21 Suppl 5():S65-70. PubMed ID: 18090271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV/AIDS: the management of treatment-experienced HIV-infected patients: new drugs and drug combinations.
    Wilson LE; Gallant JE
    Clin Infect Dis; 2009 Jan; 48(2):214-21. PubMed ID: 19072245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART): a balancing act.
    Burgoyne RW; Tan DH
    J Antimicrob Chemother; 2008 Mar; 61(3):469-73. PubMed ID: 18174196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The (political) economics of antiretroviral treatment in developing countries.
    Nattrass NJ
    Trends Microbiol; 2008 Dec; 16(12):574-9. PubMed ID: 18964022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The World Health Organization's global strategy for prevention and assessment of HIV drug resistance.
    Bennett DE; Bertagnolio S; Sutherland D; Gilks CF
    Antivir Ther; 2008; 13 Suppl 2():1-13. PubMed ID: 18578063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-resistant TB and HIV in resource-limited settings: what TB/HIV programmes can learn from each other.
    Colebunders R; Worodria W; Jones-López E; Joloba M; Apers L; Ellner J
    Trop Med Int Health; 2008 Sep; 13(9):1204-7. PubMed ID: 18664238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meeting the immense need for HAART in resource-poor settings.
    Bogaards JA; Goudsmit J
    J Antimicrob Chemother; 2003 Nov; 52(5):743-6. PubMed ID: 14563896
    [No Abstract]   [Full Text] [Related]  

  • 20. Building laboratory infrastructure to support scale-up of HIV/AIDS treatment, care, and prevention: in-country experience.
    Abimiku AG;
    Am J Clin Pathol; 2009 Jun; 131(6):875-86. PubMed ID: 19461097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.